# EDGAR Filing Document

**Accession Number:** 0001802630
**File Stem:** 0001802630-25-000009
**Filing Date:** 2025-8
**Character Count:** 45101
**Document Hash:** c63aeef6777fc3c27331f8d288988f4b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001802630-25-000009.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001802630-25-000009

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250825

**EFFECTIVENESS DATE**: 20250825

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Soleus Capital Management, L.P.
- **CENTRAL INDEX KEY:** 0001802630

**ORGANIZATION NAME:**
- **EIN:** 384052641
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20043
- **FILM NUMBER:** 251250071

**BUSINESS ADDRESS:**
- **STREET 1:** 104 FIELD POINT ROAD
- **STREET 2:** FLOOR 2
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 203-542-5527

**MAIL ADDRESS:**
- **STREET 1:** 104 FIELD POINT ROAD
- **STREET 2:** FLOOR 2
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001802630

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Soleus Capital Management, L.P.

**Address:** 100 Field Point Road, Greenwich, CT 06830

**Telephone number:** 475-208-3178

**Name of agent for service:** The Corporation Trust Company

**Agent Address:** 1209 Orange Street, Wilmington, DE 19801

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20043

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                           | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                            | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| AADI BIOSCIENCE, INC.                    | 00032Q104 | 02/28/2025     | Non-Binding Advisory Vote on Golden Parachutes Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Divestiture.                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          98789 |                0 | FOR         |                                    98789 | FOR                         |  |
| ABIVAX SA                                | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         125000 |                0 | FOR         |                                   125000 | FOR                         |  |
| ABIVAX SA                                | 00370M103 | 06/06/2025     | Please see Exhibit A of the Depositary Notice of Combined General Meeting for agenda item.                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         125000 |                0 | FOR         |                                   125000 | FOR                         |  |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION     | 00650F109 | 06/10/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers as described in the proxy statement;                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |           9183 |                0 | FOR         |                                     9183 | FOR                         |  |
| ADVERUM BIOTECHNOLOGIES, INC.            | 00773U207 | 06/17/2025     | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement.                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          67324 |                0 | FOR         |                                    67324 | FOR                         |  |
| AKERO THERAPEUTICS, INC                  | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          43420 |                0 | FOR         |                                    43420 | FOR                         |  |
| ALNYLAM PHARMACEUTICALS, INC.            | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          10273 |                0 | FOR         |                                    10273 | FOR                         |  |
| ANI PHARMACEUTICALS, INC.                | 00182C103 | 05/22/2025     | To approve the compensation of the Company's named executive officers, on a non-binding, advisory basis.                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         226993 |                0 | FOR         |                                   226993 | FOR                         |  |
| ARCELLX, INC.                            | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         148031 |                0 | FOR         |                                   148031 | FOR                         |  |
| ARGENX SE                                | 04016X101 | 05/27/2025     | The 2024 remuneration report                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          30940 |                0 | FOR         |                                    30940 | FOR                         |  |
| ASTRAZENECA PLC                          | 046353108 | 04/11/2025     | To approve the annual statement of the Chair of the Remuneration Committee and the Annual Report on Remuneration for the year ended 31 December 2024                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         312300 |                0 | FOR         |                                   312300 | FOR                         |  |
| AVADEL PHARMACEUTICALS PLC               | G29687103 | 07/30/2024     | To approve, on a non-binding advisory basis, the compensation of the named executive officers of the Company.                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         478255 |                0 | FOR         |                                   478255 | FOR                         |  |
| AVITA MEDICAL, INC.                      | 05380C102 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | FOR         |                                     1000 | FOR                         |  |
| AXOGEN, INC.                             | 05463X106 | 06/19/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        1446117 |                0 | FOR         |                                  1446117 | FOR                         |  |
| AXOGEN, INC.                             | 05463X106 | 06/19/2025     | To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        1446117 |                0 | 1 YEAR      |                                  1446117 | FOR                         |  |
| AXSOME THERAPEUTICS, INC.                | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          15530 |                0 | FOR         |                                    15530 | FOR                         |  |
| BEIGENE LTD                              | 07725L102 | 05/21/2025     | THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |             12 |                0 | FOR         |                                       12 | FOR                         |  |
| BIOMARIN PHARMACEUTICAL INC.             | 09061G101 | 05/20/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        1089304 |                0 | FOR         |                                  1089304 | FOR                         |  |
| C4 THERAPEUTICS, INC.                    | 12529R107 | 06/18/2025     | To cast a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |        5912485 |                0 | FOR         |                                  5912485 | FOR                         |  |
| CELCUITY INC.                            | 15102K100 | 05/13/2025     | To approve, by a non-binding and advisory vote, compensation of the named executive officers.                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        2432503 |                0 | FOR         |                                  2432503 | FOR                         |  |
| DELCATH SYSTEMS, INC.                    | 24661P807 | 05/15/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement ("Proxy Statement").                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         232722 |                0 | FOR         |                                   232722 | FOR                         |  |
| DENALI THERAPEUTICS INC.                 | 24823R105 | 06/03/2025     | Advisory vote on executive compensation                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         100000 |                0 | FOR         |                                   100000 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC                | 28036F105 | 06/13/2025     | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          76493 |                0 | FOR         |                                    76493 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC                | 28036F105 | 06/13/2025     | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          76493 |                0 | 1 YEAR      |                                    76493 | FOR                         |  |
| ESSA PHARMA INC.                         | 29668H708 | 03/05/2025     | The approval, on a non-binding, advisory basis, of the compensation paid to the Company's named executive officers.                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        2262026 |                0 | FOR         |                                  2262026 | FOR                         |  |
| ESTABLISHMENT LABS HOLDINGS INC.         | G31249108 | 05/23/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |            427 |                0 | FOR         |                                      427 | FOR                         |  |
| EVOLUS, INC.                             | 30052C107 | 06/05/2025     | Approval of, on an advisory basis, the compensation of Evolus' named executive officers.                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         994499 |                0 | FOR         |                                   994499 | FOR                         |  |
| GERON CORPORATION                        | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |        2400000 |                0 | FOR         |                                  2400000 | FOR                         |  |
| HCA HEALTHCARE, INC.                     | 40412C101 | 04/24/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          16400 |                0 | FOR         |                                    16400 | FOR                         |  |
| IMMUNOVANT INC                           | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         251900 |                0 | FOR         |                                   251900 | FOR                         |  |
| INSMED INCORPORATED                      | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         315772 |                0 | FOR         |                                   315772 | FOR                         |  |
| INSPIRE MEDICAL SYSTEMS, INC.            | 457730109 | 05/01/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          36644 |                0 | FOR         |                                    36644 | FOR                         |  |
| INTEGRA LIFESCIENCES HOLDINGS CORP.      | 457985208 | 05/09/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        1070423 |                0 | FOR         |                                  1070423 | FOR                         |  |
| IOVANCE BIOTHERAPEUTICS, INC.            | 462260100 | 06/10/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |        1906962 |                0 | FOR         |                                  1906962 | FOR                         |  |
| JAZZ PHARMACEUTICALS PLC                 | G50871105 | 07/25/2024     | To approve, on a non-binding advisory basis, the compensation of Jazz Pharmaceuticals plc's named executive officers as disclosed in the proxy statement.                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         132917 |                0 | FOR         |                                   132917 | FOR                         |  |
| JAZZ PHARMACEUTICALS PLC                 | G50871105 | 07/25/2024     | To indicate, on a non-binding advisory basis, the preferred frequency of the advisory vote on the compensation of Jazz Pharmaceuticals plc's named executive officers.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         132917 |                0 | 1 YEAR      |                                   132917 | FOR                         |  |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | G52694109 | 06/03/2025     | To approve, on an advisory (non-binding) basis, the Company's UK Statutory Directors' Annual Remuneration Report for the period ended December 31, 2024.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         464500 |                0 | FOR         |                                   464500 | FOR                         |  |
| KINIKSA PHARMACEUTICAL INTERNATIONAL PLC | G52694109 | 06/03/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         464500 |                0 | FOR         |                                   464500 | FOR                         |  |
| KRYSTAL BIOTECH, INC.                    | 501147102 | 05/16/2025     | Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         235396 |                0 | FOR         |                                   235396 | FOR                         |  |
| LIVANOVA PLC                             | G5509L101 | 06/11/2025     | Ordinary Resolution: To approve, on an advisory basis, the Company's compensation of its named executive officers (''US Say on Pay'').                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         107040 |                0 | FOR         |                                   107040 | FOR                         |  |
| MADRIGAL PHARMACEUTICALS INC.            | 558868105 | 06/20/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |           6786 |                0 | FOR         |                                     6786 | FOR                         |  |
| MADRIGAL PHARMACEUTICALS INC.            | 558868105 | 06/20/2025     | Advisory vote to approve the frequency of future advisory votes to approve executive compensation                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           6786 |                0 | 1 YEAR      |                                     6786 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC                | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         686953 |                0 | FOR         |                                   686953 | FOR                         |  |
| MEREO BIOPHARMA GROUP PLC                | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (nonbinding) basis.                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         686953 |                0 | 1 YEAR      |                                   686953 | AGAINST                     |  |
| MERUS N.V.                               | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         329779 |                0 | FOR         |                                   329779 | FOR                         |  |
| NOVOCURE LIMITED                         | G6674U108 | 06/04/2025     | A non-binding advisory vote to approve executive compensation.                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |        5451639 |                0 | FOR         |                                  5451639 | FOR                         |  |
| NURIX THERAPEUTICS, INC.                 | 67080M103 | 05/19/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |        2368719 |                0 | FOR         |                                  2368719 | FOR                         |  |
| NUVALENT, INC.                           | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         194357 |                0 | FOR         |                                   194357 | FOR                         |  |
| ORGANOGENESIS HOLDINGS INC               | 68621F102 | 06/23/2025     | Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company's proxy statement for its 2025 annual meeting of shareholders.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |       12478351 |                0 | FOR         |                                 12478351 | FOR                         |  |
| ORTHOFIX MEDICAL INC.                    | 68752M108 | 06/18/2025     | Advisory and Non-Binding Vote to Approve Executive Compensation.                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         601925 |                0 | FOR         |                                   601925 | FOR                         |  |
| ORTHOPEDIATRICS CORP.                    | 68752L100 | 05/23/2025     | To approve, on an advisory basis, the resolution approving the compensation of our named executive officers.                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          45000 |                0 | FOR         |                                    45000 | FOR                         |  |
| PACIRA BIOSCIENCES, INC.                 | 695127100 | 06/10/2025     | Approval, on an advisory basis, of the compensation of our named executive officers.                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          85000 |                0 | FOR         |                                    85000 | FOR                         |  |
| PACIRA BIOSCIENCES, INC.                 | 695127100 | 06/10/2025     | Advisory vote to approve the frequency of future advisory votes to approve the compensation of our named executive officers.                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          85000 |                0 | 1 YEAR      |                                    85000 | FOR                         |  |
| PRAXIS PRECISION MEDICINES, INC.         | 74006W207 | 06/26/2025     | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion. | SECTION 14A SAY-ON-PAY VOTES |        1249740 |                0 | FOR         |                                  1249740 | FOR                         |  |
| REVOLUTION MEDICINES, INC.               | 76155X100 | 06/26/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").                                                                        | SECTION 14A SAY-ON-PAY VOTES |          54784 |                0 | FOR         |                                    54784 | FOR                         |  |
| RIGEL PHARMACEUTICALS, INC.              | 766559702 | 05/22/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the accompanying proxy statement.                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |        1125601 |                0 | FOR         |                                  1125601 | FOR                         |  |
| SANOFI                                   | 80105N105 | 04/30/2025     | Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2024 to Frédéric Oudéa, Chairman of the Board                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         271218 |                0 | FOR         |                                   271218 | FOR                         |  |
| SANOFI                                   | 80105N105 | 04/30/2025     | Approval of the components of the compensation paid or awarded in respect of the year ended December 31, 2024 to Paul Hudson, Chief Executive Officer                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |         271218 |                0 | FOR         |                                   271218 | FOR                         |  |
| SAREPTA THERAPEUTICS, INC.               | 803607100 | 06/05/2025     | ADVISORY VOTE TO APPROVE, ON A NON-BINDING BASIS, NAMED EXECUTIVE OFFICER COMPENSATION                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          32580 |                0 | FOR         |                                    32580 | FOR                         |  |
| SCHOLAR ROCK HOLDING CORPORATION         | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          40803 |                0 | FOR         |                                    40803 | FOR                         |  |
| STAAR SURGICAL COMPANY                   | 852312305 | 06/18/2025     | Non-binding advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |        2093404 |                0 | FOR         |                                  2093404 | FOR                         |  |
| SURMODICS, INC.                          | 868873100 | 08/13/2024     | Approve, in a non-binding advisory vote, certain compensation that may be paid or become payable to our named executive officers in connection with the merger.                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         781777 |                0 | FOR         |                                   781777 | FOR                         |  |
| SURMODICS, INC.                          | 868873100 | 02/06/2025     | Approve, in a non-binding advisory vote, the Company's executive compensation.                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         394060 |                0 | FOR         |                                   394060 | FOR                         |  |
| SYNDAX PHARMACEUTICALS, INC              | 87164F105 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the 2025 proxy statement.                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         477713 |                0 | FOR         |                                   477713 | FOR                         |  |
| TANDEM DIABETES CARE, INC.               | 875372203 | 05/21/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         377807 |                0 | FOR         |                                   377807 | FOR                         |  |
| TANDEM DIABETES CARE, INC.               | 875372203 | 05/21/2025     | To approve, on a non-binding, advisory basis, the frequency of future stockholder advisory votes to approve the compensation of our named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         377807 |                0 | 1 YEAR      |                                   377807 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC                | 878972108 | 06/06/2025     | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          16841 |                0 | FOR         |                                    16841 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC                | 878972108 | 06/06/2025     | Advisory vote on the frequency of stockholder advisory votes on executive compensation.                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          16841 |                0 | 1 YEAR      |                                    16841 | FOR                         |  |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED   | 881624209 | 06/05/2025     | To approve, on a non-binding advisory basis, the compensation for Teva's named executive officers                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         200500 |                0 | FOR         |                                   200500 | FOR                         |  |
| TG THERAPEUTICS, INC.                    | 88322Q108 | 06/12/2025     | An advisory vote to approve the compensation of our named executive officers.                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |        2574438 |                0 | FOR         |                                  2574438 | FOR                         |  |
| THE BEAUTY HEALTH COMPANY                | 88331L108 | 06/12/2025     | Approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         220336 |                0 | FOR         |                                   220336 | FOR                         |  |
| UNITED THERAPEUTICS CORPORATION          | 91307C102 | 06/26/2025     | Advisory resolution to approve executive compensation.                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         244694 |                0 | FOR         |                                   244694 | FOR                         |  |
| VERACYTE, INC.                           | 92337F107 | 06/17/2025     | The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         622270 |                0 | FOR         |                                   622270 | FOR                         |  |
| VERACYTE, INC.                           | 92337F107 | 06/17/2025     | The selection, on a non-binding advisory basis, whether future advisory votes on the compensation paid by us to our named executive officers should be held every one, two or three years.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         622270 |                0 | 1 YEAR      |                                   622270 | FOR                         |  |
| VERASTEM, INC.                           | 92337C203 | 05/22/2025     | To approve an advisory vote on the compensation of the named executive officers.                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         439972 |                0 | FOR         |                                   439972 | FOR                         |  |
| VERICEL CORPORATION                      | 92346J108 | 04/30/2025     | To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers.                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           3661 |                0 | FOR         |                                     3661 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Soleus Capital Management, L.P.

**By (Signature):** Harold Schaaff

**By (Printed Signature):** Harold Schaaff

**By (Title):** CCO

**Date:** 08/25/2025